Quest Diagnostics Incorporated revised consolidated earnings guidance for the full year of 2022. For the year, the company now expects net revenues to be in the range of $9.50 billion to $9.75 billion and reported diluted EPS to be in the range of $8.24 to $8.64, the prior guidance of Net revenues to be in the range of $9.2 billion to $9.5 billion and Reported diluted EPS to be in the range of $7.88 to $8.38.